Neurogene Income Statement (2018-2025) | NGNE

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -0.00M1,000.00M-0.02M-0.00M-0.00M-0.00M-0.02M-0.60M-0.53M-0.02M-0.41M-0.08M-0.07M-0.04M
Operating items
Research & Development 10.51M10.71M2.57M10.28M10.32M11.61M12.18M13.54M15.74M16.29M15.35M17.76M19.37M17.24M
Selling, General & Administrative 4.31M4.48M2.73M2.56M10.38M2.42M3.57M2.75M2.27M3.61M2.55M5.24M5.32M5.89M6.17M8.16M6.71M6.56M
Other Operating Expenses 0.10M49.14M-2.00M5.50M
Operating Expenses 14.82M15.20M5.30M2.66M59.52M0.43M9.07M13.04M12.60M15.22M14.73M18.78M21.06M22.18M21.51M25.92M26.08M23.80M
Operating Income -14.82M-15.20M-5.30M-59.52M-8.36M-13.04M-12.60M-15.22M-14.73M-18.78M-20.13M-22.18M-21.51M-25.92M-26.08M-23.80M
EBIT -14.82M-15.20M-5.30M-59.52M-8.36M-13.04M-12.60M-15.22M-14.73M-18.78M-20.13M-22.18M-21.51M-25.92M-26.08M-23.80M
Non-operating items
Interest & Investment Income 0.25M0.47M0.47M0.45M0.43M0.78M0.74M0.65M0.78M2.32M2.04M1.84M2.27M3.21M2.93M2.74M
Other Non Operating Income -0.05M-0.26M1.48M0.00M0.01M16.36M0.14M0.14M0.14M0.14M0.15M1.21M0.15M
Non Operating Income 0.19M0.20M0.42M0.45M0.38M0.43M0.43M1.86M1.64M1.96M2.00M3.27M4.07M2.85M
Net income details
EBT -14.57M-14.73M-4.83M-59.52M-8.36M-12.26M-11.86M-14.57M-13.97M-17.06M-18.63M-20.36M-19.66M-22.79M-23.23M-21.10M
Profit After Tax -14.62M-14.99M-4.89M-2.21M-59.13M-0.00M-8.64M-12.30M-11.86M-14.58M13.65M-16.92M-18.49M-20.22M-19.51M-22.65M-22.02M-20.95M
Income from Continuing Operations -14.57M-14.73M-4.83M-59.52M-8.36M-12.26M-11.86M-14.57M-13.97M-17.06M-18.63M-20.36M-19.66M-22.79M-23.23M-21.10M
Consolidated Net Income -14.57M-14.73M-4.83M-59.52M-8.36M-12.26M-11.86M-14.57M-13.97M-17.06M-18.63M-20.36M-19.66M-22.79M-23.23M-21.10M
Income towards Parent Company -14.57M-14.73M-4.83M-59.52M-8.36M-12.26M-11.86M-14.57M-13.97M-17.06M-18.63M-20.36M-19.66M-22.79M-23.23M-21.10M
Net Income towards Common Stockholders -14.57M-14.73M-4.83M-59.52M-8.36M-12.26M-11.86M-14.57M-13.97M-17.06M-18.63M-20.36M-19.66M-22.79M-23.23M-21.10M
Additional items
EPS (Basic) -0.62-0.64-0.20-0.09-2.26-0.16-0.18-28.28-26.68-32.6727.76-1.00-1.09-1.19-0.99-1.08-1.05-0.99
EPS (Weighted Average and Diluted) -0.62-28.28-26.68-32.672.93-1.00-1.09-1.19-0.99-1.08-1.05-0.99
Shares Outstanding (Weighted Average) 1.17M1.18M1.18M1.18M1.18M1.18M1.18M1.92M1.92M1.92M2.09M2.14M2.14M2.20M2.35M12.85M12.98M12.99M14.85M14.93M14.26M14.27M
Shares Outstanding (Diluted Average) 23.85M23.54M49.17M49.39M54.12M0.43M0.44M0.45M4.66M16.90M16.94M16.95M17.57M21.00M21.06M21.17M
EBITDA -14.58M-14.99M-4.89M-2.21M-59.13M-0.00M-8.64M-13.04M-12.60M-15.22M-14.73M-18.78M-20.13M-22.18M-21.51M-25.92M-26.08M-23.80M
Interest Expenses 0.00M0.02M0.00M0.00M0.00M0.02M0.60M0.53M0.02M0.41M0.08M0.07M0.04M
Shares Outstanding 23.54M23.54M23.54M23.54M28.14M38.00M38.39M38.49M41.88M8.56M8.80M8.81M